32.25
-0.10
(-0.31%)
At close: 12:16:07 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
55,963.00
70,210.00
65,072.00
155,950.00
83,227.00
Investing Cash Flow
-35,941.00
-10,898.00
-10,186.00
-8,788.00
-2,635.00
Financing Cash Flow
-57,370.00
-55,402.00
-64,345.00
-54,524.00
-44,694.00
End Cash Position
390,568.00
467,406.00
463,496.00
472,955.00
380,317.00
Capital Expenditure
-3,589.00
-7,668.00
-6,739.00
-9,155.00
-2,541.00
Free Cash Flow
52,374.00
62,542.00
58,333.00
146,795.00
80,686.00
12/31/2020 - 8/20/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6662.TWO BioLASCO Taiwan Co., Ltd.
34.00
+3.03%
4131.TWO NeoCore Technology Co., Ltd.
30.95
-0.16%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
92.00
-0.11%
3164.TW GenMont Biotech Incorporation
19.40
-0.26%
3205.TWO Sagittarius Life Science Corp
33.95
0.00%
3176.TWO Medigen Biotechnology Corp.
32.10
-1.53%
4168.TWO GlycoNex Incorporation
23.85
-0.62%
1733.TW Apex Biotechnology Corp.
30.00
+0.17%
8279.TWO Syngen Biotech Co.,Ltd.
126.50
+1.61%
6461.TWO Intech Biopharm Corporation
24.65
-0.80%